HRTX HERON THERAPEUTICS, INC. /DE/companySEC Filings & Insider Trading Activity 2026
Latest HERON THERAPEUTICS, INC. /DE/ (HRTX) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on November 4, 2025, an 8-K current report filed on April 6, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for HERON THERAPEUTICS, INC. /DE/ (HRTX) (SEC CIK 818033), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 financial results released Feb 26, 2026 — details in Exhibit 99.1
- • Coverage period: three and twelve months ended December 31, 2025
Recent 8-K FilingsCurrent Reports
AI-powered analysis of HERON THERAPEUTICS, INC. /DE/ (HRTX) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 6, 2026 | — | — | — |
10-K | Feb 26, 2026 | Dec 31, 2025 | — | |
8-K | Feb 26, 2026 | — | Analysis | — |
8-K | Jan 9, 2026 | — | — | |
10-Q | Nov 4, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 8, 2025 | Jun 30, 2025 | — | |
10-Q | May 6, 2025 | Mar 31, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 6, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Mar 12, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 14, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 14, 2023 | Jun 30, 2023 | — | |
10-Q | May 11, 2023 | Mar 31, 2023 | — | |
10-K | Mar 29, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 8, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 9, 2022 | Jun 30, 2022 | — | |
10-Q | May 9, 2022 | Mar 31, 2022 | — | |
10-K | Feb 28, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 3, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 9, 2021 | Jun 30, 2021 | — | |
10-Q | May 10, 2021 | Mar 31, 2021 | — | |
10-K | Feb 24, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 5, 2020 | Sep 30, 2020 | — |
Frequently Asked Questions
What are the latest HRTX SEC filings in 2026?
HERON THERAPEUTICS, INC. /DE/ (HRTX) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2025, an 8-K current report on April 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did HRTX file its most recent 10-K annual report?
HERON THERAPEUTICS, INC. /DE/ (HRTX) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view HRTX 10-Q quarterly reports?
HERON THERAPEUTICS, INC. /DE/ (HRTX)'s most recent 10-Q quarterly report was filed on November 4, 2025. SignalX displays every HRTX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has HRTX filed recently?
HERON THERAPEUTICS, INC. /DE/ (HRTX)'s most recent 8-K was filed on April 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find HRTX insider trading activity (Form 4)?
SignalX aggregates every HRTX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does HRTX file with the SEC?
HERON THERAPEUTICS, INC. /DE/ (HRTX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new HRTX filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for HERON THERAPEUTICS, INC. /DE/ (HRTX).
What is HRTX's SEC CIK number?
HERON THERAPEUTICS, INC. /DE/ (HRTX)'s SEC CIK (Central Index Key) number is 818033. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 818033 to look up all HRTX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find HRTX return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from HERON THERAPEUTICS, INC. /DE/ (HRTX) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of HERON THERAPEUTICS, INC. /DE/ SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 66+ filings.